Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Decision Resources Group
Decision Resources Group
Activities:
Media
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Media
Chilean pharmaceutical market expected to increase at CAGR of 11.3% over next five years
Pharma landscape is small but highly competitive, finds new report from Decision Resources Group
You need to be a subscriber to read this article.
Click here
to find out more.
Drug Delivery
Drug delivery innovations set to disrupt sector
Drug formulators will have a broader range of drug delivery options in future, aiding both compliance and outcomes. Susan Birks reports
Media
Colombian pharmaceutical market expected to reach US$5.37bn by 2016
Provides an entry point into South America for multinational pharmaceutical companies
Vietnam bans companies making \'substandard\' drugs
Companies banned include 45 Indian pharmaceutical companies along with others from Korea, France and Pakistan
Media
Global biosimilars pipeline has expanded by more than 40% in 12 months, finds report
Strong growth in Brazil driven by public-private partnerships
Pharmaceutical
Biosimilars
9 April 2014, One-day seminar, London, UK
Media
Piramal Healthcare buys Decision Resources Group
Indian firm pays US$635m for healthcare information business
Subscribe now